Výsledky vyhledávání - "Yoshinari, Toru"

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Clinical efficacy, radiographic progression, and safety through 156 weeks of therapy with subcutaneous golimumab in combination with methotrexate in Japanese patients with active rheumatoid arthritis despite prior methotrexate therapy : final results of the randomized GO-FORTH trial

Autor: Tanaka, Yoshiya, Harigai, Masayoshi, Takeuchi, Tsutomu, Yamanaka, Hisashi, Ishiguro, Naoki, Yamamoto, Kazuhiko, Miyasaka, Nobuyuki, Koike, Takao, Baker, Daniel, Ishii, Yutaka, Yoshinari, Toru, The GO-FORTH study group

Publikováno v: Modern Rheumatology

Objective: To evaluate the safety and efficacy of golimumab + methotrexate (MTX) in Japanese patients with active rheumatoid arthritis (RA). Methods: Japanese patients with active RA despite MTX were randomized to placebo + MTX (Group 1, n = 88), gol

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37e35699b09d8642319d92a94e272f78
http://hdl.handle.net/2115/62847

Zobrazit plný text záznamu

Akademický článek

Apararenone in patients with diabetic nephropathy: results of a randomized, double-blind, placebo-controlled phase 2 dose–response study and open-label extension study.

Autor: Wada, Takashi, Inagaki, Masaya, Yoshinari, Toru, Terata, Ryuji, Totsuka, Naoko, Gotou, Miki, Hashimoto, Gaia

Publikováno v: Clinical & Experimental Nephrology; Feb2021, Vol. 25 Issue 2, p120-130, 11p

Zobrazit plný text záznamu

Additional file 1: of High titers of both rheumatoid factor and anti-CCP antibodies at baseline in patients with rheumatoid arthritis are associated with increased circulating baseline TNF level, low drug levels, and reduced clinical responses: a post hoc analysis of the RISING study

Autor: Takeuchi, Tsutomu, Miyasaka, Nobuyuki, Inui, Takashi, Yano, Toshiro, Yoshinari, Toru, Abe, Tohru, Koike, Takao

Distribution of RF and anti-CCP titers at week 0 in all patients (nâ =â 307). (PDF 39 kb)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95a84214b798ae1fa491a387834a9a71

Zobrazit plný text záznamu

Additional file 3: of High titers of both rheumatoid factor and anti-CCP antibodies at baseline in patients with rheumatoid arthritis are associated with increased circulating baseline TNF level, low drug levels, and reduced clinical responses: a post hoc analysis of the RISING study

Autor: Takeuchi, Tsutomu, Miyasaka, Nobuyuki, Inui, Takashi, Yano, Toshiro, Yoshinari, Toru, Abe, Tohru, Koike, Takao

RF and anti-CCP titers at weeks 0, 30, and 54. (PDF 479 kb)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e80efd3797f3436985b008e51417bbc

Zobrazit plný text záznamu

Additional file 2: of High titers of both rheumatoid factor and anti-CCP antibodies at baseline in patients with rheumatoid arthritis are associated with increased circulating baseline TNF level, low drug levels, and reduced clinical responses: a post hoc analysis of the RISING study

Autor: Takeuchi, Tsutomu, Miyasaka, Nobuyuki, Inui, Takashi, Yano, Toshiro, Yoshinari, Toru, Abe, Tohru, Koike, Takao

Stratification of patients based on RF and anti-CCP titers at week 0. (PDF 419 kb)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fbd835edf6ced97a5101dfec858b5b6

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Golimumab in combination with methotrexate in Japanese patients with active rheumatoid arthritis : results of the GO-FORTH study

Autor: Tanaka, Yoshiya, Harigai, Masayoshi, Takeuchi, Tsutomu, Yamanaka, Hisashi, Ishiguro, Naoki, Yamamoto, Kazuhiko, Miyasaka, Nobuyuki, Koike, Takao, Kanazawa, Minoru, Oba, Takuya, Yoshinari, Toru, Baker, Daniel, The GO-FORTH Study Group

Publikováno v: Annals of the Rheumatic Diseases

Objective: To assess the efficacy and safety of golimumab + methotrexate (MTX) in Japanese patients with active rheumatoid arthritis (RA). Methods: 269 Japanese patients with active RA despite treatment with MTX were randomised (1:1:1) to placebo + M

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29f5ad1bafecca0c43fda3cf8d5a16c7
http://hdl.handle.net/2115/62832

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání